Zai Lab Ltd
ZLAB18.000USD
+1.020+6.01%
終値 02/06, 16:00（ET）15分遅れの株価
1.99B時価総額
損失額直近12ヶ月PER
詳細情報 Zai Lab Ltd 企業名
Zai Lab Ltd is a holding company primarily engaged in biopharmaceuticals. The Company is committed to addressing the unmet medical needs in the fields of tumors, autoimmune diseases, infectious diseases and central nervous system diseases through product discovery, development and commercialization. The Company has a series of patented drug candidates from the discovery stage to the late clinical project. These include ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others.
Zai Lab Ltdの企業情報
企業コードZLAB
会社名Zai Lab Ltd
上場日Sep 28, 2020
最高経営責任者「CEO」Du (Ying)
従業員数1869
証券種類Depository Receipt
決算期末Sep 28
本社所在地Building B, 899 Halei Road, Pudong
都市SHANGHAI
証券取引所NASDAQ OMX - NASDAQ BASIC
国China
郵便番号201203
電話番号862161632588
ウェブサイトhttps://www.zailaboratory.com/
企業コードZLAB
上場日Sep 28, 2020
最高経営責任者「CEO」Du (Ying)
Zai Lab Ltdの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. John David Diekman, Ph.D.
Dr. John David Diekman, Ph.D.
Lead Independent Director
Lead Independent Director
99.77K
+10831.00%
Mr. Joshua L. Smiley
Mr. Joshua L. Smiley
President, Chief Operating Officer
President, Chief Operating Officer
86.60K
+10000.00%
Mr. William David (Bill) Lis
Mr. William David (Bill) Lis
Independent Director
Independent Director
35.11K
-2983.00%
Dr. Yajing Chen, Ph.D.
Dr. Yajing Chen, Ph.D.
Chief Financial Officer
Chief Financial Officer
17.44K
-240.00%
Dr. Ying (Samantha) Du, Ph.D.
Dr. Ying (Samantha) Du, Ph.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Ms. Leung (Nisa Bernice) Wing-Yu
Ms. Leung (Nisa Bernice) Wing-Yu
Independent Director
Independent Director
--
--
Mr. Peter Karl Wirth, J.D.
Mr. Peter Karl Wirth, J.D.
Independent Director
Independent Director
--
--
Mr. Leon Oliver (Lonnie) Moulder, Jr.
Mr. Leon Oliver (Lonnie) Moulder, Jr.
Independent Director
Independent Director
--
--
Mr. Frazor Titus Edmondson, J.D.
Mr. Frazor Titus Edmondson, J.D.
Company Secretary, Chief Legal Officer
Company Secretary, Chief Legal Officer
--
--
Mr. Scott W. Morrison, CPA
Mr. Scott W. Morrison, CPA
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. John David Diekman, Ph.D.
Dr. John David Diekman, Ph.D.
Lead Independent Director
Lead Independent Director
99.77K
+10831.00%
Mr. Joshua L. Smiley
Mr. Joshua L. Smiley
President, Chief Operating Officer
President, Chief Operating Officer
86.60K
+10000.00%
Mr. William David (Bill) Lis
Mr. William David (Bill) Lis
Independent Director
Independent Director
35.11K
-2983.00%
Dr. Yajing Chen, Ph.D.
Dr. Yajing Chen, Ph.D.
Chief Financial Officer
Chief Financial Officer
17.44K
-240.00%
Dr. Ying (Samantha) Du, Ph.D.
Dr. Ying (Samantha) Du, Ph.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Ms. Leung (Nisa Bernice) Wing-Yu
Ms. Leung (Nisa Bernice) Wing-Yu
Independent Director
Independent Director
--
--
収益内訳
通貨: USD更新時刻: Tue, Jan 6
通貨: USD更新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
事業別USD
会社名
収益
比率
ZEJULA
42.43M
36.78%
VYVGART
27.73M
24.03%
NUZYRA
15.43M
13.38%
Optune
12.66M
10.97%
QINLOCK
8.90M
7.72%
他の
8.21M
7.12%
地域別USD
会社名
収益
比率
China (Mainland)
116.09M
0.00%
事業別
地域別
事業別USD
会社名
収益
比率
ZEJULA
42.43M
36.78%
VYVGART
27.73M
24.03%
NUZYRA
15.43M
13.38%
Optune
12.66M
10.97%
QINLOCK
8.90M
7.72%
他の
8.21M
7.12%
株主
更新時刻: Sat, Feb 7
更新時刻: Sat, Feb 7
株主統計
種類
株主統計
株主統計
比率
Capital World Investors
5.39%
Fidelity Management & Research Company LLC
3.79%
Norges Bank Investment Management (NBIM)
3.41%
ClearBridge Investments, LLC
3.12%
RTW Investments L.P.
2.03%
他の
82.26%
株主統計
株主統計
比率
Capital World Investors
5.39%
Fidelity Management & Research Company LLC
3.79%
Norges Bank Investment Management (NBIM)
3.41%
ClearBridge Investments, LLC
3.12%
RTW Investments L.P.
2.03%
他の
82.26%
種類
株主統計
比率
Investment Advisor
15.68%
Investment Advisor/Hedge Fund
12.47%
Sovereign Wealth Fund
3.58%
Hedge Fund
2.94%
Individual Investor
1.78%
Private Equity
1.44%
Venture Capital
1.12%
Research Firm
0.61%
Pension Fund
0.02%
他の
60.34%
機関投資家保有株
更新時刻: Wed, Jan 21
更新時刻: Wed, Jan 21
報告期間
機関投資家数
保有株式数
比率
変動額
2026Q4
280
37.42M
42.38%
--
2025Q4
369
40.92M
36.54%
-16.68M
2025Q3
372
46.61M
41.70%
-15.37M
2025Q2
394
60.58M
54.15%
-11.96M
2025Q1
453
59.51M
53.68%
-14.18M
2024Q4
446
60.80M
55.47%
-4.29M
2024Q3
439
51.45M
51.99%
-10.14M
2024Q2
454
47.04M
47.66%
-14.67M
2024Q1
465
46.22M
46.47%
-13.77M
2023Q4
497
46.31M
46.92%
-16.57M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Capital World Investors
6.08M
5.43%
+41.48K
+0.69%
Sep 30, 2025
Fidelity Management & Research Company LLC
4.28M
3.82%
-610.67K
-12.50%
Sep 30, 2025
ClearBridge Investments, LLC
3.52M
3.14%
-492.62K
-12.28%
Sep 30, 2025
RTW Investments L.P.
2.29M
2.05%
-3.25M
-58.62%
Sep 30, 2025
Janus Henderson Investors
2.05M
1.83%
-148.32K
-6.75%
Sep 30, 2025
Wellington Management Company, LLP
1.72M
1.53%
+341.49K
+24.80%
Sep 30, 2025
Frazier Life Sciences Management, L.P.
1.63M
1.45%
+319.18K
+24.40%
Sep 30, 2025
Baron Capital Management, Inc.
1.37M
1.22%
-216.57K
-13.64%
Sep 30, 2025
詳細を見る
関連ETF
更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
Tema Oncology ETF
1.67%
ALPS Medical Breakthroughs ETF
1.19%
Virtus LifeSci Biotech Products ETF
0.97%
Invesco Golden Dragon China ETF
0.58%
National Security Emerging Markets Index ETF
0.39%
iShares Biotechnology ETF
0.18%
Capital Group New Geography Equity ETF
0.15%
ProShares Ultra Nasdaq Biotechnology
0.12%
Invesco Nasdaq Biotechnology ETF
0.12%
ActivePassive International Equity ETF
0.03%
詳細を見る
Tema Oncology ETF
比率1.67%
ALPS Medical Breakthroughs ETF
比率1.19%
Virtus LifeSci Biotech Products ETF
比率0.97%
Invesco Golden Dragon China ETF
比率0.58%
National Security Emerging Markets Index ETF
比率0.39%
iShares Biotechnology ETF
比率0.18%
Capital Group New Geography Equity ETF
比率0.15%
ProShares Ultra Nasdaq Biotechnology
比率0.12%
Invesco Nasdaq Biotechnology ETF
比率0.12%
ActivePassive International Equity ETF
比率0.03%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
